این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Pathology، جلد ۱۹، شماره ۱، صفحات ۱-۹
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Current Understanding of PCSK9 and Its Relevance to Cancer Prognosis and Immune Therapy: A Review
چکیده انگلیسی مقاله The effectiveness of immunotherapy for most cancer patients remains low, with approximately 10–30% of those treated surviving. Thus, much effort is being put into finding new ways to improve immune checkpoint therapy. Our review concludes that the inhibition of proprotein convertase subtilisin/Kexin type 9 (PCSK9), which plays a critical role in regulating cholesterol metabolism, can cause T cells to move toward tumors, with increased sensitivity to immune checkpoint therapies.
We searched PubMed, NCBI, Scopus, and Google Scholar for the published articles without limitations on publication dates. We used the following terms: “PCSK9”, “Cancer”, “Immune Checkpoint”, and “Cancer Prognosis” in the title and/or abstract. Our search initially revealed 600 records on the subject and stored them in the used databases under EndNote X8 management software. We selected about 161 articles that were carefully read and among them, 76 were included in our research.
We concluded that PCSK9 reduces the number of LDL receptors (LDL-R) on the cell surface, which is linked to its ability to regulate cholesterol levels in the body. Also, we discuss how suppressing PCSK9 leads to the MHC-1 accumulation on the surface of cancer cells, which results in T lymphocyte invasion. Finally, we believe that inhibiting PCSK9 may be an effective strategy for improving cancer immunotherapy.
کلیدواژه‌های انگلیسی مقاله PCSK9, Immunotherapy, Cancer, Immune checkpoint
نویسندگان مقاله Morteza Hassandokht Mashhadi |
Department of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran

Fahimeh Taheri |
B.Sc. of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran

Sadaf Irani |
Department of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran

Arshiya Mesbah Mousavi |
Department of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran

Ali Mehri |
Endoscopic and Minimally Invasive Surgery Research Center, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

Hossein Javid |
Department of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran

نشانی اینترنتی https://ijp.iranpath.org/article_709723_053c2339989ee9b31e9df59f7675c8b1.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات